Drug Delivery

Boehringer Ingelheim reports asthma, COPD patients are satisfied with soft mist inhaler

Published in Health and Medicine Week, October 2nd, 2006

The results of an observational study presented at the 16th Annual Congress of the European Respiratory Society in Munich, Germany show that patients with asthma and chronic obstructive pulmonary disease (COPD) are highly satisfied with the novel Respimat Soft Mist Inhaler (SMI) from Boehringer Ingelheim.

In a 12 week observational cohort study in respiratory specialist practices in Germany, the handling, including device assembly, inhalation satisfaction and technique were assessed with a clinical questionnaire. Two thousand six patients from 695 centres in Germany were interviewed after 4, 8 and 12 weeks of 2-4 times daily administration of ipratropium...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week

Source: Health and Medicine Week (2006-10-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry